Key result
There was a significant modest positive correlation between treatment satisfaction and self-efficacy (r = 0.345, p < 0.001) among patients receiving anticoagulant therapy.
Why the study?
Anticoagulants have characteristics that strongly affect compliance and satisfaction, but the relationship between treatment satisfaction and self-efficacy among these patients remained to be explored.
Cross-Sectional (n=300)
No
Effect estimate: r = 0.345
p-value: p=<0.001
Higher self-efficacy is modestly correlated with greater treatment satisfaction in patients on anticoagulant therapy, with NOAC users reporting better scores than VKA users.
NOAC users reported higher satisfaction and self-efficacy than VKA/UFH users; cross-sectional data leaves open effects on adherence or outcomes.
BACKGROUND: Thromboembolic events are a common complicated health problem. Although anticoagulants have several positive effects on these conditions, they also have several characteristics that strongly affect compliance and satisfaction. The purpose of this investigation is to explore the association between treatment satisfaction and self-efficacy in a sample of patients using anticoagulation therapy and determine the influence of sociodemographic and clinical factors on both aspects. METHODS: This was a cross-sectional exploratory study carried out in Palestine. The Arabic version of the Anti-Coagulant Treatment Satisfaction Scale (ACTS) assessed treatment satisfaction. In addition, the Arabic version of the 6-Item Self-Efficacy for Managing Chronic Diseases (SES6C) was used to assess self-efficacy. RESULTS: A total of 300 patients using anticoagulants (average age 51.95 and SD 17.98) were included. There is a modest correlation between treatment satisfaction and self-efficacy (r = 0.345; p < 0.001). The mean and median self-efficacy scores were 38.41 ± 9.88 and 39.00 (interquartile range: 33.00-46.00), respectively. Overall, patients reported a moderate burden and benefit score. The mean and median of the acting burden were 43.30 ± 10.45, and 43.30 (interquartile range: 36.00 to 51.00), respectively. The results showed that young age, higher education, employment, use of fewer medications, and having fewer diseases were significantly associated with higher self-efficacy behaviors. The results also showed that new oral anti-coagulants (NOACs) had a higher degree of self-efficacy and ACTS benefit scores (41.00 (33.75-47.00), p = 0.002; 13.00 (12.00-15.00), p < 0.001, respectively), than vitamin k antagonists (VKA). CONCLUSIONS: The results demonstrated a significant relationship between treatment satisfaction and self-efficacy, and certain sociodemographic and clinical characteristics influence both. We found that there is a higher degree of self-efficacy and treatment satisfaction among patients who use NOACs than those who use UFH / VKA. Therefore, patients should be motivated to increase their knowledge about anticoagulant therapy. Healthcare providers should play an active role in educating patients, increasing their self-esteem, and awareness about anticoagulant drugs. Importantly, this study was an explanatory one, and it includes a low proportion of patients with venous thromboembolism. This encourages future research on a large scale of patients, considering the indications of anticoagulant therapy.
No takes yet. Share an insight, caveat, or question.
Al‐Jabi et al. (2022) conducted a cross-sectional in Patients using anticoagulant therapy (n=300). Anticoagulant therapy was evaluated on Correlation between treatment satisfaction and self-efficacy (r = 0.345, p=<0.001). There was a significant modest positive correlation between treatment satisfaction and self-efficacy (r = 0.345, p < 0.001) among patients receiving anticoagulant therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: